Please login to the form below

Licensing deals

This page shows the latest Licensing deals news and features for those working in and with pharma, biotech and healthcare.

Merck & Co’s sales bounce back in ‘ongoing recovery from COVID-19’

In June, Merck completed the spin-off of women’s health company Organon, freeing up approximately $9bn for new deals and collaborations. ... Executing value-enhancing business development is a top priority, and we intend to add to our pipeline through

Latest news

Gilead swoops on Forty Seven with $4.9bn all-cash deal

Takeover is latest in a string of billion-plus deals signed by Gilead. ... The takeover is the latest in a string of big billion dollar-plus licensing and acquisition deals signed by Gilead since the start of 2019 under new chief executive Daniel
Takeda buys coeliac disease partner PvP Biologics after phase 1 win

There has been a flurry of licensing deals in the coeliac disease area in recent months, including deals between GlaxoSmithKline and Sitari and Roche/Genentech and Parvus, as drugmakers eye a
Boehringer bolsters NASH pipeline with Enleofen link-up

It’s the first licensing deal for the company and is also thought to be the largest ever agreed by a Singapore biotech, with Boehringer agreeing to pay up to 1bn ( ... a series of licensing deals as well as its in-house research.
AstraZeneca launches $1bn Chinese investment fund

generic products, over a ten-year period, and has agreed licensing deals for three early-stage cancer drugs with Chinese biotech firms.
Pfizer pays $250m upfront to Akcea for phase 2 antisense drug

Has potential in cardiovascular and metabolic diseases. Pfizer has bolted on an antisense drug with potential in cardiovascular and metabolic diseases to its pipeline via a licensing deal with Ionis’ Akcea ... affiliate. The big pharma – which has

More from news
Approximately 2 fully matching, plus 87 partially matching documents found.

Latest Intelligence

Sourcing R&D innovation: why pharma companies need to evolve their business models

the pipeline, the use of technology in medicine is expected to grow and so are the associated deals, mergers and acquisitions. ... They also can help identify collaboration opportunities including partnerships, licensing deals and merger or acquisition
20 for 2020 – Five pharma leaders to watch in 2020

returns. That includes an exit from areas like neurology – which predates Bourla’s appointment as CEO but was set up while he was COO – and a series of bolt-on deals ... Meanwhile, Galapagos looks set to continue adding to its pipeline through
A market-adapted agile approach to launch excellence

Furthermore, increases. in region or market-specific licensing deals for launch products have led companies to devolve to region-specific cross-functional teams for tailored launch preparation, allowing different thinking to
The changing nature of approvals – what does the future hold?

Mega-mergers are also becoming less frequent; instead, we’re seeing fewer but larger deals. ... Based on CMR International data, since 2015 we have seen the number of drug commercialisation/licensing deals continue to gradually decline while the
Deal Watch October 2018

Licensing &. research. collaboration. $550m. Novartis/. Mylan. TOBI Podhaler and TOBI solution for cystic fibrosis. ... Licensing &. collaboration. $40m. All deals are for worldwide rights unless stated otherwise:.

More from intelligence
Approximately 0 fully matching, plus 33 partially matching documents found.

Latest appointments

Ablynx appoints Markus Ewert as chief business officer

Edwin Moses, CEO of Ablynx, said: “Markus brings extensive experience in leading business development teams and executing licensing deals and acquisitions.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Account Manager - Healthcare Consultancy: Salary depending on experience

Senior Medical Writer/ Copywriter, Flexible Location, Flexible D...: Salary TBC

Digital Engagement Strategist, Healthcare Brand Communications, ...: £75-90K

Project Director, Healthcare Marketing Agency patient focus Lond...: Highly competitive salary

Events Executive: Depending on Experience

Senior Consultant, Pricing & Market Access Consultancy, circ...: circa £100K package

Digital Project Director, Healthcare Marketing Agency patient fo...: Highly competitive salary

Group Account Director, Patient focussed account, Healthcare com...: circa £90K

Digital account director: Competitive

Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...: Highly competitive salary

PMHub

Add my company

ROAD

ROAD is a digital PR and communications consultancy specialising in promoting the innovators that shape our future health and wellbeing....

Latest intelligence

Ask the writers: Transitioning from academia to medical writing: Porterhouse Medical's talented writers talk about their transition from academia and give advice to those people considering a career in medical writing...
Strategic launch planning: familiar framework, new mindset: By James Aird...
Guide: How to embrace behavioural science principles in healthcare MR...

Email:
Password:

Please login to the form below

Licensing deals

COVID-19 Updates and Daily News

Featured jobs

Quick links